Positron Corporation

POSC ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Jun 2025 Mar 2025 Sep 2015 Jun 2015 Mar 2015 Dec 2014
Revenue $111.8K $111.0K $120.1K $119.3K $304.0K $328.0K $346.0K $259.0K
Cost of Revenue $376.7K $637.8K $402.4K $377.0K $197.0K $190.0K $210.0K $232.0K
Gross Profit $-264.9K $-526.8K $-282.3K $-257.7K $107.0K $138.0K $136.0K $27.0K
Gross Margin -236.9% -474.6% -235.0% -216.0% 35.2% 42.1% 39.3% 10.4%
Operating Expenses
Research & Development — — — — $2.0K $5.0K $120.0K $123.0K
SG&A Expense $539.0K $838.1K $887.7K $1.2M $255.0K $332.0K $505.0K $506.0K
Operating Income $-803.9K $-1.4M $-1.2M $-1.5M $-170.0K $-223.0K $-531.0K $-644.0K
Operating Margin -718.9% -1,229.7% -974.0% -1,238.1% -55.9% -68.0% -153.5% -248.6%
Interest Expense $21.8K $23.3K $29.9K $34.9K $141.0K $142.0K $136.0K $14.0K
Pretax Income — — — — $-255.0K $-375.0K $-554.0K $-86.0K
Income Tax Expense — — — — $0 $0 $0 $0
Net Income $-821.4K $-1.4M $-1.2M $-1.5M $-255.0K $-375.0K $-554.0K $86.0K
Net Margin -734.6% -1,241.2% -991.3% -1,267.4% -83.9% -114.3% -160.1% 33.2%
EPS (Basic) $-0.03 $-0.04 $-0.04 $-0.05 $-0.02 $-0.03 $-0.04 $0.00
EPS (Diluted) $-0.03 $-0.04 $-0.04 $-0.05 $-0.02 $-0.03 $-0.04 $0.00
Shares Outstanding (Basic) 32.8M 32.8M 31.3M 29.1M 14.3M 14.3M 14.3M 5.55B
Shares Outstanding (Diluted) 32.8M 32.8M 31.3M 29.1M 14.3M 14.3M 14.3M 5.55B
Dividends Per Share — — — — — — — —
← Newer Page 1 of 4 Older →